期刊文献+

88例甲状腺微小乳头状癌诊治分析 被引量:7

Diagnosis and treatment of thyroid papillary microcarcinoma: An analysis of 88 cases
下载PDF
导出
摘要 目的探讨甲状腺微小乳头状癌的临床诊疗特点。方法回顾性分析我科2008年1月-2012年1月收治的88例经病理证实的甲状腺微小乳头状癌患者的病例资料。结果 88例术前均行颈部超声或超声引导下细针穿刺活检,漏诊率为15.9%,术中冰冻检查漏诊率为6.6%。所有患者均行手术治疗,5例行治疗性中央区淋巴结清扫,6例行预防性中央区淋巴结清扫,术后证实颈部淋巴结转移5例。所有患者术后均口服优甲乐片。随访3~56个月,仅2例复发。结论应重视甲状腺微小乳头状癌的特点,正确诊断及规范术式是治疗本病的关键。 Objective To study the diagnosis and treatment of thyroid papillary microcarcinoma(TPMC).Methods Clinical data about 88 pathology-confirmed TPMC patients admitted to our department from January 2008 to January 2012 were retrospectively analyzed.Results The TPMC patients were diagnosed by fine needle biopsy under ultrasonic guidance,with a missed diagnosis rate of 15.9% and an intraoperative fast freezing missed diagnosis rate of 6.6%.Of the patients who underwent surgical treatment,5 underwent therapeutic central compartment lymph node dissection,6 underwent prophylactic central compartment lymph node dissection,and 5 were eventually diagnosed with cervical metastasis.The patients were treated with oral euthyrox tablets after operation and followed up for 3-56 months during which TPMC recurred only in 2 patients.Conclusion Attention should be paid to the clinical features of TPMC.Correct diagnosis and standard procedure are the key to its treatment.
出处 《解放军医学院学报》 CAS 2013年第5期449-451,457,共4页 Academic Journal of Chinese PLA Medical School
关键词 甲状腺微小乳头状癌 手术切除 淋巴结清扫 thyroid papillary microcarcinoma surgical resection lymph node dissection
  • 相关文献

参考文献17

  • 1Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J].{H}Human Reproduction,2004,(01):19-25.
  • 2Carmassi F,De Negri F,Fioriti R. Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome[J].{H}Thrombosis research,2005,(03):207-214.
  • 3Lindholm A,Bixo M,Eliasson M. Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome[J].{H}Gynecological Endocrinology,2010,(10):743-748.
  • 4Coolman M,de Groot CJ,Steegers EA. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally,during and after pregnancy[J].{H}European Journal of Obstetrics Gynecology and Reproductive Biology,2006,(1-2):22-28.
  • 5Brenner B. Haemostatic changes in pregnancy[J].{H}Thrombosis research,2004,(5-6):409-414.
  • 6Kjerulff LE,Sanchez-Ramos L,Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome:a metaanalysis[J].{H}AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY,2011,(06):558.e1-558.e6.
  • 7Glueck CJ,Wang P,Bornovali S. Polycystic ovary syndrome,the G1691A factor V Leiden mutation,and plasminogen activator inhibitor activity:associations with recurrent pregnancy loss[J].{H}Metabolism-Clinical and experimental,2003,(12):1627-1632.
  • 8Manner?s-Holm L,Baghaei F,Holm G. Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome[J].{H}Journal of Clinical Endocrinology and Metabolism,2011,(04):1068-1076.
  • 9Sangle GV,Zhao R,Shen GX. Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells[J].{H}American Journal of Physiology Endocrinology and Metabolism,2008,(05):E1243-E1254.
  • 10Gerrits AJ,Koekman CA,van Haeften TW. Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin[J].{H}DIABETES,2010,(06):1487-1495.

同被引文献47

引证文献7

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部